As 4kids and farrell's posts have pointed out, $IPIX is
As 4kids and farrell's posts have pointed out, $IPIX is executing a detailed plan to advance their science with the goal of forming strategic partnerships to accelerate getting their drugs to market. Yooper61, Chemdeps and others have picked up on key quotes both written and from their shareholder meeting notes. As Kelt pointed out it appears likely that Locust’s influence to secure deals is already in motion and IMO they have their fingerprints on $IPIX’s 10k which is much more strongly written than in years past. As AlanC pointed out from the 10k, Leo is well aware of the criminal intent of NR. Leo and Dr. Bertolino have been laying out crumbs that all of us have picked up on. I am as excited as everyone else about when and what the next deal will bring but let’s not lose sight of what the bigger picture looks like.
1) Advance the science through FDA trials. (Kevetrin and multiple instances of Brilacidin).
2) Establish partners to assist in #1 and #3 (Evonic, CoreRX, BDD, Locust Walk etc.)
3) Pharmaceutical partnerships to complete trials and bring drugs to market and create royalty revenue to $IPIX. (Alfasigma was the Brilacidin foundation deal with IMO much larger and more lucrative deals to follow shortly.)
4) Collect multiple royalty streams from multiple partnerships and instances. Alfasigma is the first example with B-IBD UP/UPS. Separate deals and additional streams are B-OM (probably next), B-IBD colitis pill (huge), B-dermatitis, B-ABSSSI, Kevetrin (huge) and more than likely several other markets and instances.
5) Up list off of the criminally controlled OTX on to NASDAQ
6) Lastly: Sell the company after all the above has taken place as $IPIX becomes fairly valued as it has multiple revenue streams with multiple drugs with multiple instances. ( Never publicly stated by $IPIX but JMHO at some logical point.)
The above are not necessarily in order although IMO #6 will happen last. NR knows this list as well as us Longs do. Guess what the SMB crew hired by NR will be saying? "Gee the SP is at 10 cents if you get $2/share that is a 20 bagger! If you get $3 that is 30x!" They will say this to try to steal your shares at $2 or $3. Look at the list above and plug your own guess as to where SP will be as $IPIX executes their strategy. Each step of #4, #5 and #6 will IMO create huge gap ups in SP….but before you make your guess do one more math exercise....
Remember that 150M to 14M shareholder vote FOR. That tells us the FACT that over 90% of $IPIX shares are strongly held and it is doubtful that this 90%+ will sell their shares cheaply. Let’s assume there are approximately 250M shares Outstanding at the time that a non-dilutive partnership with BP gets inked (The first of more to come). That means less than 25M (10% or so) $IPIX shares would be in a lower trading range. IMO the NSS count of vapor shares is actually HIGHER than this 25M trading share count. NSS could very well represent 40M or more vapor shares. (Don’t let the bashers confuse you with the legal short count which is a minor number.) If these numbers are anywhere close to reality, is there any question why and how IPIX share price is so compressed and artificially depressed? When a new deal is inked and new investors join us on the demand side, where is the supply going to come from to provide the sell side for millions of transactions? What is NR going to do? IMO they are going to pick off all GTC orders in the sub $3-$4 range so that they can try to rinse and repeat. Don’t let the criminals steal your shares cheaply. Now go back up and make your own guess to where IPIX share price will be as IPIX executes and achieves multiple #4's and ultimately #5 and #6 above. Exciting times ahead for $IPIX shareholders IMO.
16
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...
Continue Reading
Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...
Continue Reading
Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Top 5 Most Recently Viewed Articles
Animating a Vision for Better Relations In a world where tensions between law enforcement and the public can feel like walking on a tightrope, the National Police Association (NPA) decided to switch gears with an animated public service announcement (PSA). Aiming to foster better police-community relations, they rolled out a new TV campaign starring "Officer Mike," a...
Continue Reading
Growth of Mixed and Extended Reality Headsets Recent analyses indicate that the market for mixed and extended reality headsets is poised for significant growth in the upcoming years. This shift towards these technologies is set to transform how users interact with digital environments. Current Trends in Headset Shipments A recent report highlights that shipments of...
Continue Reading
Supernus Pharmaceuticals Makes Strategic Acquisition Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) has completed a significant acquisition, enhancing its portfolio with the addition of Sage Therapeutics, Inc. (NASDAQ: SAGE). This strategic move not only strengthens Supernus' existing product line but also diversifies its revenue sources, aligning with its long-term growth...
Continue Reading
Quiddity Engineering made waves when it appointed Ryan Ingram as the Division Manager for its new Environmental service line. This wasn't just some run-of-the-mill hire; it was a power move to ramp up their capabilities in tackling environmental challenges that clients face. You know how it goes—companies can’t afford to sit still in this game, especially with all the...
Continue Reading
Bringing Verzenios to the Forefront in China From San Francisco to Suzhou, the buzz is all about Innovent Biologics teaming up with Eli Lilly to push Verzenios (abemaciclib) deeper into the Chinese market. This collaboration is like fitting the final piece of a jigsaw puzzle. Innovent's got the ground troops ready with its robust commercialization engine, while Lilly...
Continue Reading